Find your next paid study

Stanford UniversityNCT05540574

~$75 – $2,000

Actual pay is set by the research site.

Phase 2

A Phase II Study of Pembrolizumab, Olaparib, and Temozolomide in Patients With Glioma

This study will test the safety and effectiveness of a combination of pembrolizumab, olaparib, and temozolomide to see how well these drugs work when given tog…

Glioma

Memorial Sloan Kettering Cancer CenterNCT05188508

~$75 – $2,000

Actual pay is set by the research site.

Mohs Micrographic SurgeryCutaneous MalignancyMohs Surgical Defect

A Multicenter, Prospective, Randomized Controlled Clinical Trial Assessing the Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.

A multicenter, prospective, randomized controlled clinical trial assessing the efficacy of a novel cellular, acellular, matrix-like product (CAMP) plus standar…

BioLab HoldingsNCT07695389

~$10 – $1,125

Actual pay is set by the research site.

Mobile ApplicationsCancer Patients

Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity

The overarching purpose of this study is to assess whether patients will use the app throughout treatment on a regular basis, as the ultimate goal is to provid…

Montefiore Medical CenterNCT06860425

~$10 – $750

Actual pay is set by the research site.

Myeloid MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes

HM2023-05: GTB-3650 (Anti-CD16/IL-15/Anti-CD33) Tri-Specific Killer Engager (TriKE®) for the Treatment of High Risk Myelodysplastic Syndromes (MDS) and Refractory/Relapsed Acute Myeloid Leukemia (AML)

This is a Phase I dose finding study of GTB-3650 (anti-CD16/IL-15/anti-CD33) Tri-Specific Killer Engager (TriKE®) for the treatment of select CD33-expressing r…

Masonic Cancer Center, University of MinnesotaNCT06594445

~$150 – $3,000

Actual pay is set by the research site.

Phase 4

Optimizing Antibiotic Selection in Hematologic Malignancy Patients With Reported Beta-lactam Allergy - Intervention

The overall goal of the RENEW-IN intervention is to assess the impact of a BL allergy delabeling intervention on antibiotic use and clinical outcomes in patien…

Beta Lactam AllergyHematologic Malignancy

Abramson Cancer Center at Penn MedicineNCT07133074

~$25 – $1,000

Actual pay is set by the research site.

Fracture ArmFracture LegWrist Injury+1 more

MSK Injury Assessment Imaging System: Feasibility and Data Acquisition for Algorithm Development and Testing

The Accuro XV is a cart-based, bedside ultrasound instrument that incorporates new signal processing-based technologies for enhanced bone and soft-tissue imagi…

Rivanna Medical, Inc.NCT07853768

~$10 – $1,050

Actual pay is set by the research site.

Phase 2

Human Penile Allotransplantation

Injuries to the genitalia are of concern to the military with emphasis placed on the surgical reconstruction and psychological health of these Wounded Warriors…

AmputationWounds and InjuriesAmputation, Traumatic+6 more

Johns Hopkins UniversityNCT02395497

~$75 – $2,000

Actual pay is set by the research site.

Acute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

This is an open label, non-randomized, phase 1 study of anti-CD19 CAR-T cells against relapsed CD19 positive NHL, CLL and ALL based in a lymphodepletion regime…

University of UtahNCT06227026

~$150 – $3,000

Actual pay is set by the research site.

A Phase 1, Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-SUDV-GP Vaccine in Adults in Good General Health

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in G…

Sudan Virus Disease

International AIDS Vaccine InitiativeNCT07565090

~$500 – $11,250

Actual pay is set by the research site.

Caregiver BurdenAlzheimer's DiseaseDementia+2 more

WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCT

The goal of this clinical trial is to learn if a newly-created website tool, called WeCareToFeedDysphagia, helps to reduce feelings of burden in care partners …

Northwell HealthNCT07250113

~$10 – $1,125

Actual pay is set by the research site.

Systemic SclerosisSclerodactyly

Digital Intradermal Hyaluronidase for Sclerodactyly in Systemic Sclerosis

Translational studies have demonstrated reduced hyaluronidase activity in the skin of patients with systemic sclerosis. It is thought this may contribute to th…